Misfill Regulatory Status: A Guide for Professional Buyers

Misfill is a brand of hyaluronic acid (HA) dermal fillers developed and produced by Medical Lab Co., Ltd., a company based in South Korea. Understanding the product's origin is the first step in assessing its regulatory standing. South Korea has a mature and dynamic aesthetic market, with its own robust regulatory framework governed by the Ministry of Food and Drug Safety (MFDS), formerly known as the KFDA.

Products originating from South Korea, like many in the Hyaluronic acid dermal filler catalog, typically secure domestic approval before being distributed to international markets. This KFDA clearance is a foundational quality indicator that many non-EU and non-US markets recognize.

Misfill fillers are approved for use within South Korea and hold the necessary certifications from the MFDS (KFDA). This approval confirms that the product complies with the country-of-origin's standards for safety, quality, and manufacturing processes.

For international buyers, KFDA approval serves as a baseline for product legitimacy. It indicates that the manufacturer operates under the oversight of a national health authority. This is a critical piece of documentation to verify when assessing any product sourced from the Korean aesthetic market. More details on the broader market context can be found in our report on Sourcing for Your Clinic: An Update on the Korean Dermal Fil.

The CE mark is a mandatory conformity marking for products sold within the European Economic Area (EEA). For medical devices like dermal fillers, the CE mark indicates that the product meets the EU's Medical Device Regulation (MDR) or the preceding Medical Device Directive (MDD) requirements for safety and performance.

Currently, Misfill's CE mark status is [VERIFY: Misfill CE mark status and certification body]. Clinics operating within the EU or in markets that use the CE mark as a standard for import must confirm the product's current certification status with their supplier. Without a valid CE mark, the product cannot be legally placed on the market in these regions.

The primary question for many international buyers relates to United States Food and Drug Administration (FDA) approval. FDA approval is a rigorous process specific to the US market.

As of the latest available information, Misfill dermal fillers are not FDA-approved. This is common for many aesthetic products manufactured outside the US, including numerous popular Korean brands such as Elasty Plus 1CC. Consequently, Misfill cannot be legally marketed or sold for aesthetic use within the United States. Professionals in other regions should be aware of this distinction, as FDA approval is often used as a global benchmark but is not a legal requirement for import or use in most other countries.

Beyond market-specific approvals, global manufacturing standards provide another layer of quality assurance. Medical Lab Co., Ltd. manufactures its products in facilities that adhere to Good Manufacturing Practice (GMP) standards. GMP ensures that products are consistently produced and controlled according to quality protocols.

Additionally, manufacturers often seek ISO certification, such as ISO 13485, which is the standard for medical device quality management systems. When sourcing Misfill, professionals should request documentation from their supplier confirming the manufacturer's compliance with GMP and any relevant ISO certifications. These credentials validate the quality of the production environment, independent of regional market approvals.

For clinics and distributors in the Gulf Cooperation Council (GCC), Latin America (LATAM), and Asia-Pacific (APAC) regions, the regulatory pathway is often different. In many of these markets, direct FDA approval or a CE mark is not a prerequisite for importation and use.

Instead, national health authorities may accept KFDA approval coupled with GMP certification as sufficient evidence of safety and quality for local registration. Some countries may require product registration with their own ministries of health. It is the responsibility of the importer or clinic to understand and comply with local regulations. Always work with a supplier who can provide the necessary documentation, such as a Certificate of Free Sale (CFS) from the country of origin, to facilitate registration.